A state audit in Colorado has exposed significant gaps in cannabis regulatory oversight, with inspectors moving too slowly and rules being insufficiently stringent to prevent potentially contaminated products from reaching store shelves. The findings highlight critical weaknesses in quality control testing and enforcement mechanisms that are meant to protect consumers. This is particularly concerning for medical cannabis patients who depend on safe, uncontaminated products for therapeutic use. The audit calls for stronger state regulations and faster processing times to ensure product safety and consumer protection in the legal cannabis market.
